(Q54549757)

English

Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/18070184

Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/18070184

chemoradiotherapy

0 references

author name string

Suárez J

1

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/18070184

Vera R

2

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/18070184

Balén E

3

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/18070184

Gómez M

4

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/18070184

Arias F

5

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/18070184

Lera JM

6

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/18070184

Herrera J

7

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/18070184

Zazpe C

8

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/18070184

publication date

7 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/18070184

Colorectal Disease

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/18070184

10

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/18070184

6

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/18070184

563-568

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/18070184

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2007.01424.X

21 January 2018

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2007.01424.X

21 January 2018

Chemotherapy with preoperative radiotherapy in rectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2007.01424.X

21 January 2018

Recommendations for the reporting of surgically resected specimens of colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2007.01424.X

21 January 2018

Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2007.01424.X

21 January 2018

Response to neoadjuvant therapy for rectal cancer: influence on long-term results.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2007.01424.X

21 January 2018

Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2007.01424.X

21 January 2018

Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2007.01424.X

21 January 2018

Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2007.01424.X

21 January 2018

Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2007.01424.X

21 January 2018

Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2007.01424.X

21 January 2018

Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2007.01424.X

21 January 2018

A histopathological assessment of the response of rectal adenocarcinoma to combination chemo-radiotherapy: relationship to apoptotic activity, p53 and bcl-2 expression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2007.01424.X

21 January 2018

Preoperative parameters expanding the indication of sphincter preserving surgery in patients with advanced low rectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2007.01424.X

21 January 2018

Response to preoperative chemoradiation in stage II and III rectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2007.01424.X

21 January 2018

Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2007.01424.X

21 January 2018

Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2007.01424.X

21 January 2018

Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2007.01424.X

21 January 2018

Identifiers

10.1111/J.1463-1318.2007.01424.X

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/18070184

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/18070184

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54549757&oldid=940547398"